FDA.reportPublic FDA data

NDC 73198-023

This exact product or package identity exists in FDA auxiliary data but is not present in the current primary NDC product table. The package identity is preserved; status rows are reported source observations, not medical conclusions.

Requested NDC
73198-023
Product root
73198-023
Identity scope
Product
Primary current NDC product row
Not present

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 12 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
compounderpackage73198-02373198-023-03COMPOUNDEROutsourcing facility compounded drug report2026-12026-09-18
compounderpackage73198-02373198-023-10COMPOUNDEROutsourcing facility compounded drug report2026-12026-09-18
compounderpackage73198-02373198-023-05COMPOUNDEROutsourcing facility compounded drug report2026-12026-09-18
compounderpackage73198-02373198-023-05COMPOUNDEROutsourcing facility compounded drug report2026-12026-10-06
compounderpackage73198-02373198-023-10COMPOUNDEROutsourcing facility compounded drug report2026-12026-10-06
compounderpackage73198-02373198-023-03COMPOUNDEROutsourcing facility compounded drug report2026-12026-10-06
compounderpackage73198-02373198-023-03COMPOUNDEROutsourcing facility compounded drug report2023-12026-10-06
compounderpackage73198-02373198-023-10COMPOUNDEROutsourcing facility compounded drug report2023-12026-10-06
compounderpackage73198-02373198-023-05COMPOUNDEROutsourcing facility compounded drug report2023-12026-10-06
compounderpackage73198-02373198-023-03COMPOUNDEROutsourcing facility compounded drug report2022-22026-10-06
compounderpackage73198-02373198-023-05COMPOUNDEROutsourcing facility compounded drug report2022-22026-10-06
compounderpackage73198-02373198-023-10COMPOUNDEROutsourcing facility compounded drug report2022-22026-10-06

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 12 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Package NDC, Reporting period table
Captured / source datePackage NDCReporting periodSnapshotSource SHA-256
2025-08-27 00:00 UTC · source 2025-08-2073198-023-102023-1af8e9b524e63…ca326a94a5e9…
2025-08-27 00:00 UTC · source 2025-08-2073198-023-052023-1af8e9b524e63…ca326a94a5e9…
2025-08-27 00:00 UTC · source 2025-08-2073198-023-032023-1af8e9b524e63…ca326a94a5e9…
2025-08-27 00:00 UTC · source 2025-08-2073198-023-032022-2af8e9b524e63…ca326a94a5e9…
2025-08-27 00:00 UTC · source 2025-08-2073198-023-052022-2af8e9b524e63…ca326a94a5e9…
2025-08-27 00:00 UTC · source 2025-08-2073198-023-102022-2af8e9b524e63…ca326a94a5e9…
2025-01-13 04:20 UTC · source 2024-11-2073198-023-052023-185f958c8d153…997044a9741e…
2025-01-13 04:20 UTC · source 2024-11-2073198-023-032023-185f958c8d153…997044a9741e…
2025-01-13 04:20 UTC · source 2024-11-2073198-023-102023-185f958c8d153…997044a9741e…
2025-01-13 04:20 UTC · source 2024-11-2073198-023-032022-285f958c8d153…997044a9741e…
2025-01-13 04:20 UTC · source 2024-11-2073198-023-102022-285f958c8d153…997044a9741e…
2025-01-13 04:20 UTC · source 2024-11-2073198-023-052022-285f958c8d153…997044a9741e…

Compounder NDC reports#

Browse the complete compounder directory for this NDC · Browse every current compounder row in the unified auxiliary catalog · browse compounder source captures and parsed snapshots.

Establishment, FEI, Product NDC table
EstablishmentFEIProduct NDCPackage NDCProductActive ingredientsReporting periodNormalization
Olympia Pharmacy73198-02373198-023-03Papaverine Hydrochloride 30 mg/mL Phentolamine Mesylate 3 mg/mL Alprostadil 40 mcg/mL3 mg/1 mL; 40 ug/1 mL; 30 mg/1 mL2026-1valid
OLYMPIA PHARMACY01767436873198-02373198-023-03Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride3 mg/1 mL; 40 ug/1 mL; 30 mg/1 mL2026-1valid
Olympia Pharmacy73198-02373198-023-05Papaverine Hydrochloride 30 mg/mL Phentolamine Mesylate 3 mg/mL Alprostadil 40 mcg/mL3 mg/1 mL; 40 ug/1 mL; 30 mg/1 mL2026-1valid
OLYMPIA PHARMACY01767436873198-02373198-023-05Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride3 mg/1 mL; 40 ug/1 mL; 30 mg/1 mL2026-1valid
Olympia Pharmacy73198-02373198-023-10Papaverine Hydrochloride 30 mg/mL Phentolamine Mesylate 3 mg/mL Alprostadil 40 mcg/mL3 mg/1 mL; 40 ug/1 mL; 30 mg/1 mL2026-1valid
OLYMPIA PHARMACY01767436873198-02373198-023-10Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride3 mg/1 mL; 40 ug/1 mL; 30 mg/1 mL2026-1valid
OLYMPIA PHARMACY01767436873198-02373198-023-03Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride3 mg/1 mL; .04 mg/1 mL; 30 mg/1 mL2023-1valid
OLYMPIA PHARMACY01767436873198-02373198-023-05Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride3 mg/1 mL; .04 mg/1 mL; 30 mg/1 mL2023-1valid
OLYMPIA PHARMACY01767436873198-02373198-023-10Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride3 mg/1 mL; .04 mg/1 mL; 30 mg/1 mL2023-1valid
OLYMPIA PHARMACY01767436873198-02373198-023-03Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride3 mg/1 mL; .04 mg/1 mL; 30 mg/1 mL2022-2valid
OLYMPIA PHARMACY01767436873198-02373198-023-05Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride3 mg/1 mL; .04 mg/1 mL; 30 mg/1 mL2022-2valid
OLYMPIA PHARMACY01767436873198-02373198-023-10Phentolamine Mesylate; Alprostadil; Papaverine Hydrochloride3 mg/1 mL; .04 mg/1 mL; 30 mg/1 mL2022-2valid

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.